Est. 23 March 2021

Uyirie Logics

Uyirie Logics provides personalized, precision cancer therapeutics simplified in a microfluidic device.

Founding Members

Gokula Nathan Kasinathan
Co-founder
Graduate Research Student
5 years in cancer research
Akshay Bhatt
Co-founder
Graduate Research Student
3 years in cancer research

Team Members

  • 2 Co-founder

Target Market

  • Cancer affected people

Sector

  • HealthTech

Problem Statement

Globally cancer is the second leading cause of death while the economic burden of cancer is worsening. Exploiting 3D microfluidic approaches, subjecting the patient to specific tumour biopsies in their microfluidic device. The startup, mimicking the relevant pathophysiological conditions, will be able to predict the right combination of drugs that can work with high efficacies.

Value Proposition

The device will play an immense role in personalized therapies; especially in cancer patients.

Current Stage

  • Prototype

Type of Business

  • Product-based

Products / Services

Microfluidic Device platforms for personalized cancer treatments.

Key Highlights

  • N/A

Disclaimer: The information shared in the document is provided by the startup. Uyirie Logics shall not be held responsible for the authenticity shared by the startup.

image
image
image
image